scholarly journals Radiofrequency Ablation of Benign Thyroid Nodules and Recurrent Thyroid Cancers: Consensus Statement and Recommendations

2012 ◽  
Vol 13 (2) ◽  
pp. 117 ◽  
Author(s):  
Dong Gyu Na ◽  
Jeong Hyun Lee ◽  
So Lyung Jung ◽  
Ji-hoon Kim ◽  
Jin Yong Sung ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Consensus Statement ◽  
Thyroid Cancers ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers

2016 ◽  
Vol 27 (8) ◽  
pp. 3128-3137 ◽  
Author(s):  
Cherry Kim ◽  
Jeong Hyun Lee ◽  
Young Jun Choi ◽  
Won Bae Kim ◽  
Tae Yon Sung ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Thyroid Cancers ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review

2014 ◽  
Vol 119 (7) ◽  
pp. 512-520 ◽  
Author(s):  
Irene Chiara De Bernardi ◽  
Chiara Floridi ◽  
Alessandra Muollo ◽  
Roberta Giacchero ◽  
Gian Lorenzo Dionigi ◽  
...  
Keyword(s):  
Interventional Radiology ◽  
Radiofrequency Ablation ◽  
Literature Review ◽  
Thyroid Nodules ◽  
Thyroid Cancers ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

Our experience in the first year of radiofrequency ablation of benign thyroid nodules

2018 ◽  
Author(s):  
Raul Rodriguez Escobedo ◽  
Silvia Gonzalez Martinez ◽  
Fernando Garcia Urruzola ◽  
Soraya Lanes Iglesias ◽  
Alicia Martin Nieto ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
First Year ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

What Is the Role of Radiofrequency Ablation for Benign Thyroid Nodules?

2021 ◽  
Author(s):  
Peter Horwich ◽  
Brent A. Chang ◽  
Ameya A. Asarkar ◽  
Gregory W. Randolph ◽  
Cherie‐Ann O. Nathan
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

scholarly journals CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules

2020 ◽  
Vol 37 (1) ◽  
pp. 742-748
Author(s):  
Yangsean Choi ◽  
So-Lyung Jung ◽  
Jinhee Jang ◽  
Na-Young Shin ◽  
Kook-Jin Ahn ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Quantitative Evaluation ◽  
Thyroid Nodules ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

scholarly journals Efficacy and safety of radiofrequency ablation for benign thyroid nodules in patients with previous thyroid lobectomy

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lin Yan ◽  
Mingbo Zhang ◽  
Fang Xie ◽  
Jun Ma ◽  
Jing Xiao ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Symptom Score ◽  
Thyroid Function ◽  
Thyroid Nodules ◽  
Efficacy And Safety ◽  
Thyroid Lobectomy ◽  
The Mean ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid

Abstract Background Radiofrequency ablation (RFA) is recommended for the treatment of benign thyroid nodules. However, data on the clinical role of RFA for benign thyroid nodules in patients with history of thyroid lobectomy are insufficient. The purpose of this study was to evaluate the efficacy and safety of radiofrequency ablation (RFA) for benign thyroid nodules in patients who had previously undergoing thyroid lobectomy. Methods From May 2015 to October 2018, a total of 20 patients (19 females, 1 male, mean age 49.50 ± 14.26 years, range 22–74 years) with 20 benign thyroid nodules (mean volume 15.04 ± 21.17 ml, range 0.40–69.67 ml) who had undergone previous thyroid lobectomy were included in this retrospective study. Patients were followed up at 3, 6, 12 months after RFA and every 12 months thereafter by ultrasound, clinical evaluation and thyroid function. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated. Results During the mean follow-up time of 21.24 ± 16.41 months, the mean nodule volume decreased significantly from 15.04 ± 21.17 ml to 1.29 ± 1.17 ml (P = 0.018) with a mean VRR of 85.41 ± 12.17%. Therapeutic success was achieved in a single session for all thyroid nodules. The symptom score (P = 0.001) and cosmetic score (P = 0.001) were both significantly reduced at the last follow-up. The levels of free triiodothyronine (fT3), free thyroxine (fT4) and thyroid stimulating hormone were not significantly different at the last follow-up from those prior to treatment (all P > 0.05). No life-threatening complications or sequelae occurred after RFA. Conclusions As a minimally invasive modality, RFA was a safe, effective, and thyroid function-preserving option for patients with symptomatic benign thyroid nodules after a previous lobectomy.

Sign in / Sign up

Export Citation Format

Share Document